Did Three Overdose-Associated Toronto Samples Prove Xylazine Caused Those Events?

Three of 46 xylazine-positive submissions to Toronto’s Drug Checking Service were associated with a reported overdose. The paper does not establish that xylazine caused any of those three events.

What the report actually counted

Bowles and colleagues studied drug-checking submissions, not a controlled comparison of overdose outcomes. Within a September 2020 to February 2021 group, they identified 46 xylazine-containing samples. Three were linked to an overdose report, which is 6.5% of those 46 submissions. The authors explain that overdose indications supplied by service users were self-reported.

Why causation remains open

The positive samples commonly contained other substances the authors considered noteworthy. Among the 46 xylazine-containing samples, fentanyl appeared in 43 and etizolam in 35. The paper’s test result cannot isolate the pharmacologic contribution of xylazine from those co-present substances, differences in dose, medical history, or the circumstances of use.

Many submissions were used drug administration equipment. A residue result may reflect prior uses of equipment and cannot automatically be translated into the composition or amount taken in a single event. The authors expressly discuss reuse as a limitation.

The defensible inference

The study documents xylazine in the service’s tested stream and a small number of submissions connected with reported overdoses. A case-specific causal opinion would require the clinical timeline, exposure evidence, toxicology, other drugs, and alternative explanations. The association in this paper is a reason to investigate those facts, not a substitute for them.

Source: Bowles JM, McDonald K, Maghsoudi N, et al. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduction Journal. 2021;18:104. doi:10.1186/s12954-021-00546-9

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Does Naloxone in a Xylazine-Positive Urine Sample Prove an Overdose Rescue?

Naloxone appeared in 156 of 413 xylazine-positive urine samples in Holt and colleagues’ outpatient testing cohort. That finding alone does not prove a recent overdose or emergency reversal. What the paper counted The researchers reviewed provider-ordered urine toxicology tests from April 2021 through March 2022. In their xylazine-positive group, 156…

Spread the love

Read Article: Does Naloxone in a Xylazine-Positive Urine Sample Prove an Overdose Rescue?

Did Three Overdose-Associated Toronto Samples Prove Xylazine Caused Those Events?

Three of 46 xylazine-positive submissions to Toronto’s Drug Checking Service were associated with a reported overdose. The paper does not establish that xylazine caused any of those three events. What the report actually counted Bowles and colleagues studied drug-checking submissions, not a controlled comparison of overdose outcomes. Within a September…

Spread the love

Read Article: Did Three Overdose-Associated Toronto Samples Prove Xylazine Caused Those Events?

What If a Drug-Checking Sample Lacks the Drug the Submitter Expected?

Short answer: If a checked sample does not contain the drug the submitter expected, an unexpected opioid finding may reflect a mistaken or misrepresented sample rather than an opioid added to a confirmed expected drug. Wallace and colleagues treated these as different scenarios in their British Columbia analysis. What was…

Spread the love

Read Article: What If a Drug-Checking Sample Lacks the Drug the Submitter Expected?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us